Decreased mitochondrial oxidative phosphorylation capacity in the human heart with left ventricular systolic dysfunction

European Journal of Heart Failure

Volumn 15, Issue 2, 2013, Pages 150-157

  Stride, Nis ^a   Larsen, Steen ^a   Hey Mogensen, Martin ^a   Sander, Kåre ^b   Lund, Jens T ^b   Gustafsson, Finn ^b   Køber, Lars ^b   Dela, Flemming ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Beta oxidation; Heart failure; Mitochondrial creatine kinase; Mitochondrial function; Substrates

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CITRATE SYNTHASE; CREATINE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; MEDIUM CHAIN FATTY ACID; MITOCHONDRIAL CREATINE KINASE; OCTANOYL LEVO CARNITINE; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; ENZYME SUBSTRATE; FATTY ACID OXIDATION; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE; HEART MUSCLE BIOPSY; HEART MUSCLE CELL; HEART RATE; HEART VALVE; HUMAN; INHIBITION KINETICS; LEFT VENTRICULAR ASSIST DEVICE; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MALE; MITOCHONDRIAL RESPIRATION; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIROMETRY; SENSITIVITY ANALYSIS; SINUS RHYTHM; WESTERN BLOTTING;

AGED; BIOPSY; CARNITINE; CREATINE; CREATINE KINASE, MITOCHONDRIAL FORM; ENERGY METABOLISM; FATTY ACIDS; FEMALE; HEART FAILURE, SYSTOLIC; HEART VALVE PROSTHESIS IMPLANTATION; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIA, HEART; MITOCHONDRIAL DISEASES; MYOCARDIUM; OXIDATIVE PHOSPHORYLATION; REFERENCE VALUES; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84872567025     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfs172     Document Type: Article

References (37)

1. Neubauer S, Horn M, Cramer M, Harre K, Newell JB, Peters W, Pabst T, Ertl G, Hahn D, Ingwall JS, Kochsiek K. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 1997; 96:2190-2196. (Pubitemid 27425822)
2. Hardy CJ, Weiss RG, Bottomley PA, Gerstenblith G. Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy. Am Heart J 1991;122:795-801.
3. Neubauer S. The failing heart-an engine out of fuel. N Engl J Med 2007; 356:1140-1151. (Pubitemid 46425598)
4. Hom J, Sheu SS. Morphological dynamics of mitochondria-a special emphasis on cardiac muscle cells. J Mol Cell Cardiol 2009;46:811-820.
5. Ashrafian H, Frenneaux MP, Opie LH. Metabolic mechanisms in heart failure. Circulation 2007;116:434-448. (Pubitemid 47196549)
6. Ventura-Clapier R, Garnier A, Veksler V, Joubert F. Bioenergetics of the failing heart. Biochim Biophys Acta 2011;1813:1360-1372.
7. Taylor M, Wallhaus TR, Degrado TR, Russell DC, Stanko P, Nickles RJ, Stone CK. An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in patients with congestive heart failure. J Nucl Med 2001;42:55-62. (Pubitemid 32104778)
8. Neglia D, De Caterina A, Marraccini P, Natali A, Ciardetti M, Vecoli C, Gastaldelli A, Ciociaro D, Pellegrini P, Testa R, Menichetti L, L'Abbate A, Stanley WC, Recchia FA. Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 2007;293:H3270-H3278. (Pubitemid 350230867)
9. Davila-Roman VG, Vedala G, Herrero P, de las Fuentes L, Rogers JG, Kelly DP, Gropler RJ. Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy. J Am Coll Cardiol 2002;40:271-277. (Pubitemid 34756287)
10. Chandler MP, Kerner J, Huang H, Vazquez E, Reszko A, Martini WZ, Hoppel CL, Imai M, Rastogi S, Sabbah HN, Stanley WC. Moderate severity heart failure does not involve a downregulation of myocardial fatty acid oxidation. Am J Physiol Heart Circ Physiol 2004;287:H1538-H1543. (Pubitemid 39313257)
11. Barth AS, Kumordzie A, Frangakis C, Margulies KB, Cappola TP, Tomaselli GF. Reciprocal transcriptional regulation of metabolic and signaling pathways correlates with disease severity in heart failure. Circ Cardiovasc Genet 2011;4:475-483.
12. Lemieux H, Semsroth S, Antretter H, Hofer D, Gnaiger E. Mitochondrial respiratory control and early defects of oxidative phosphorylation in the failing human heart. Int J Biochem Cell Biol 2011;43:1729-1738.
13. Authors/Task Force Members, McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Sanchez MA, Jaarsma T, Køber L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A; ESC Committee for Practice Guidelines (CPG), Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S; Document Reviewers, McDonagh T, Sechtem U, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012;14:803-869.
14. Knöll R, Iaccarino G, Tarone G, Hilfiker-Kleiner D, Bauersachs J, Leite-Moreira AF, Sugden PH, Balligand JL. Towards a re-definition of 'cardiac hypertrophy' through a rational characterization of left ventricular phenotypes: a position paper of the Working Group 'Myocardial Function' of the ESC. Eur J Heart Fail 2011; 13:811-819.
15. Tuunanen H, Ukkonen H, Knuuti J. Myocardial fatty acid metabolism and cardiac performance in heart failure. Curr Cardiol Rep 2008;10:142-148.
16. Lionetti V, Stanley WC, Recchia FA. Modulating fatty acid oxidation in heart failure. Cardiovasc Res 2011;90:202-209.
17. Ventura-Clapier R, Garnier A, Veksler V. Energy metabolism in heart failure. J Physiol 2004;555:1-13. (Pubitemid 38313058)
18. Doenst T, Abel ED. Spotlight on metabolic remodelling in heart failure. Cardiovasc Res 2011;90:191-193.
19. Sack MN, Rader TA, Park S, Bastin J, McCune SA, Kelly DP. Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. Circulation 1996; 94:2837-2842. (Pubitemid 26411749)
20. Wilcken B. Fatty acid oxidation disorders: outcome and long-term prognosis. J Inherit Metab Dis 2010;33:501-506.
21. Sharov VG, Todor AV, Silverman N, Goldstein S, Sabbah HN. Abnormal mito-chondrial respiration in failed human myocardium. J Mol Cell Cardiol 2000; 32:2361-2367. (Pubitemid 32039785)
22. Garnier A, Zoll J, Fortin D, N'Guessan B, Lefebvre F, Geny B, Mettauer B, Veksler V, Ventura-Clapier R. Control by circulating factors of mitochondrial function and transcription cascade in heart failure: a role for endothelin-1 and angiotensin II. Circ Heart Fail 2009;2:342-350.
23. Felker GM. Coenzyme Q10 and statins in heart failure: the dog that didn't bark. J Am Coll Cardiol 2010;56:1205-1206.
24. McMurray JJ, Dunselman P, Wedel H, Cleland JG, Lindberg M, Hjalmarson A, Kjekshus J, Waagstein F, Apetrei E, Barrios V, Bohm M, Kamensky G, Komajda M, Mareev V, Wikstrand J. Coenzyme Q10, rosuvastatin, and clinical outcomes in heart failure: a pre-specified substudy of CORONA (controlled rosu-vastatin multinational study in heart failure). J Am Coll Cardiol 2010;56:1196-1204.
25. Fumagalli S, Fattirolli F, Guarducci L, Cellai T, Baldasseroni S, Tarantini F, Di BM, Masotti G, Marchionni N. Coenzyme Q10 terclatrate and creatine in chronic heart failure: a randomized, placebo-controlled, double-blind study. Clin Cardiol 2011;34:211-217.
26. Sander S, Coleman CI, Patel AA, Kluger J, White CM. The impact of coenzyme Q10 on systolic function in patients with chronic heart failure. J Card Fail 2006; 12:464-472. (Pubitemid 46106977)
27. Saks VA, Belikova YO, Kuznetsov AV, Khuchua ZA, Branishte TH, Semenovsky ML, Naumov VG. Phosphocreatine pathway for energy transport: ADP diffusion and cardiomyopathy. Am J Physiol 1991;261(4 Suppl):30-38.
28. Saks V, Belikova Y, Vasilyeva E, Kuznetsov A, Fontaine E, Keriel C, Leverve X. Correlation between degree of rupture of outer mitochondrial membrane and changes of kinetics of regulation of respiration by ADP in permeabilized heart and liver cells. Biochem Biophys Res Commun 1995;208:919-926.
29. Guzun R, Gonzalez-Granillo M, Karu-Varikmaa M, Grichine A, Usson Y, Kaambre T, Guerrero-Roesch K, Kuznetsov A, Schlattner U, Saks V. Regulation of respiration in muscle cells in vivo by VDAC through interaction with the cyto-skeleton and MtCK within mitochondrial interactosome. Biochim Biophys Acta 2012;1818:1545-1554.
30. Guzun R, Karu-Varikmaa M, Gonzalez-Granillo M, Kuznetsov AV, Michel L, Cottet-Rousselle C, Saaremae M, Kaambre T, Metsis M, Grimm M, Auffray C, Saks V. Mitochondria-cytoskeleton interaction: distribution of beta-tubulins in cardiomyocytes and HL-1 cells. Biochim Biophys Acta 2011;1807:458-469.
31. Jarreta D, Orus J, Barrientos A, Miro O, Roig E, Heras M, Moraes CT, Cardellach F, Casademont J. Mitochondrial function in heart muscle from patients with idiopathic dilated cardiomyopathy. Cardiovasc Res 2000;45: 860-865. (Pubitemid 30089647)
32. Scheubel RJ, Tostlebe M, Simm A, Rohrbach S, Prondzinsky R, Gellerich FN, Silber RE, Holtz J. Dysfunction of mitochondrial respiratory chain complex I in human failing myocardium is not due to disturbed mitochondrial gene expression. J Am Coll Cardiol 2002;40:2174-2181. (Pubitemid 36005905)
33. Karamanlidis G, Nascimben L, Couper GS, Shekar PS, del MF, Tian R. Defective DNA replication impairs mitochondrial biogenesis in human failing hearts. Circ Res 2010;106:1541-1548.
34. Sylven C, Lin L, Jansson E, Sotonyi P, Fu LX, Waagstein F, Hjalmarsson A, Marcus C, Bronnegard M. Ventricular adenine nucleotide translocator mRNA is upregulated in dilated cardiomyopathy. Cardiovasc Res 1993;27: 1295-1299. (Pubitemid 23250911)
35. Nascimben L, Ingwall JS, Pauletto P, Friedrich J, Gwathmey JK, Saks V, Pessina AC, Allen PD. Creatine kinase system in failing and nonfailing human myocardium. Circulation 1996;94:1894-1901. (Pubitemid 26349302)
36. Beauloye C, Bertrand L, Horman S, Hue L. AMPK activation, a preventive therapeutic target in the transition from cardiac injury to heart failure. Cardiovasc Res 2011;90:224-233.
37. Kalsi KK, Smolenski RT, Pritchard RD, Khaghani A, Seymour AM, Yacoub MH. Energetics and function of the failing human heart with dilated or hypertrophic cardiomyopathy. Eur J Clin Invest 1999;29:469-477. (Pubitemid 29271636)